Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria
Open Access
- 22 November 2009
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 8 (1), 261
- https://doi.org/10.1186/1475-2875-8-261
Abstract
Facilitation of endogenous neuroprotective pathways, such as the erythropoietin (Epo) pathway, has been proposed as adjuvant treatment strategies in cerebral malaria. Whether different endogenous protein expression levels of Epo or differences in the abundance of its receptor components could account for the extent of structural neuropathological changes or neurological complications in adults with severe malaria was investigated.Keywords
This publication has 56 references indexed in Scilit:
- Safety of epoietin beta-quinine drug combination in children with cerebral malaria in MaliMalaria Journal, 2009
- Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malariaProceedings of the National Academy of Sciences, 2008
- Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous systemBrain Research, 2008
- High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malariaProceedings of the National Academy of Sciences, 2008
- Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malariaMalaria Journal, 2008
- Does the neuroprotective agent Erythropoietin amplify diffuse axonal injury in its early stages?Medical Hypotheses, 2007
- Post‐ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemiaBritish Journal of Pharmacology, 2007
- Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malariaJournal of the Neurological Sciences, 2007
- Role of erythropoietin in the brainCritical Reviews in Oncology/Hematology, 2007
- Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxiaProceedings of the National Academy of Sciences, 2006